← Back to Search

Brachytherapy

Online Education Program for Gynecologic Cancer Care (BrachDEP Trial)

N/A

Waitlist Available

Led By Janet Papadakos, PhD, MEd

Research Sponsored by University Health Network, Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years of age or older

Scheduled to receive brachytherapy for treatment of gynecologic cancer at Princess Margaret Cancer Centre

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

BrachDEP Trial Summary

This trial will test whether an online education program can help patients manage late side effects from gynecological cancer treatment, which can prevent adequate disease detection and negatively impact quality of life.

Who is the study for?

This trial is for adults over 18 who can read and write in English, diagnosed with gynecologic cancer, and scheduled to receive brachytherapy at Princess Margaret Cancer Centre. They must be able to give informed consent. Those not undergoing brachytherapy are excluded.Check my eligibility

What is being tested?

The study is testing a new online education program (BrachDEP) against the regular standard of care education for patients receiving brachytherapy for gynecologic cancers. The goal is to improve self-management and reduce vaginal toxicity post-treatment.See study design

What are the potential side effects?

While this trial focuses on educational interventions rather than medical treatments, potential side effects may relate more to discomfort or stress from learning new information or using technology.

BrachDEP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am scheduled for brachytherapy at Princess Margaret Cancer Centre for gynecologic cancer.

Select...

I am scheduled for brachytherapy at Princess Margaret Cancer Centre for gynecologic cancer.

BrachDEP Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Patient Satisfaction with access to education (CBI)

Patient Satisfaction with access to education (EORTC-QOL)

Patient Satisfaction with access to education (EQ-5D-5L)

+2 more

Secondary outcome measures

Rates of vaginal stenosis

BrachDEP Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Online educationExperimental Treatment1 Intervention

Participants will gain access to the online education modules in addition to receiving current standard of care education (pamphlets and one on one teaching with health care provider)

Group II: Regular standard of care educationActive Control1 Intervention

Participants only receive current standard of care education (pamphlets and one on one teaching with health care provider)

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor

1,468 Previous Clinical Trials

484,369 Total Patients Enrolled

5 Trials studying Gynecologic Cancers

1,258 Patients Enrolled for Gynecologic Cancers

Janet Papadakos, PhD, MEdPrincipal InvestigatorPrincess Margaret Cancer Centre

Media Library

Brachytherapy (Brachytherapy) Clinical Trial Eligibility Overview. Trial Name: NCT04707937 — N/A

Gynecologic Cancers Research Study Groups: Online education, Regular standard of care education

Gynecologic Cancers Clinical Trial 2023: Brachytherapy Highlights & Side Effects. Trial Name: NCT04707937 — N/A

Brachytherapy (Brachytherapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04707937 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining opportunities for participants in this trial?

"This study, which was initially posted on August 19th 2020 has ceased recruiting participants. However, there are 72 other clinical trials currently accepting patients as of April 8th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Evaluation of a Brachytherapy Discharge Education Program to Improve Patient Care

2020. "Evaluation of a Brachytherapy Discharge Education Program to Improve Patient Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04707937.